| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.894 | 0.002 | 0.894 | Angiogenesis stimulant | 0.752 0.004 DBMET01883 0.636 0.005 DBMET01884 | ||
| 0.763 | 0.002 | 0.846 | Glutamate dehydrogenase inhibitor | 0.846 0.001 DBMET01883 0.096 0.033 DBMET01884 | DBMET01883 | |
| 0.765 | 0.005 | 0.765 | Amyloid beta aggregation inhibitor | 0.496 0.014 DBMET01883 0.258 0.055 DBMET01884 | ||
| 0.754 | 0.003 | 0.754 | Dual specificity phosphatase 3 inhibitor | 0.518 0.006 DBMET01883 0.339 0.022 DBMET01884 | ||
| 0.747 | 0.003 | 0.747 | Dual specificity phosphatase inhibitor | 0.51 0.006 DBMET01883 0.319 0.025 DBMET01884 | ||
| 0.702 | 0.004 | 0.702 | Hepatoprotectant | 0.458 0.009 DBMET01883 0.446 0.01 DBMET01884 | ||
| 0.68 | 0.016 | 0.695 | Cyclophilin D inhibitor | 0.578 0.031 DBMET01883 0.695 0.014 DBMET01884 | DBMET01884 | |
| 0.657 | 0.001 | 0.657 | GABA C receptor antagonist | 0.328 0.004 DBMET01883 0.093 0.089 DBMET01884 | ||
| 0.652 | 0.005 | 0.652 | Apoptosis antagonist | 0.608 0.009 DBMET01883 0.622 0.008 DBMET01884 | ||
| 0.638 | 0.004 | 0.638 | Amyloid beta precursor protein antagonist | 0.291 0.019 DBMET01883 | ||
| 0.619 | 0.016 | 0.912 | Cholesterol antagonist | 0.668 0.01 DBMET01883 0.912 0.002 DBMET01884 | DBMET01884 | |
| 0.607 | 0.004 | 0.607 | Chelator | 0.462 0.005 DBMET01883 0.176 0.029 DBMET01884 | ||
| 0.586 | 0.002 | 0.619 | Sodium/bile acid cotransporter inhibitor | 0.541 0.003 DBMET01883 0.619 0.002 DBMET01884 | DBMET01884 | |
| 0.588 | 0.004 | 0.588 | Protein-tyrosine phosphatase inhibitor | 0.43 0.007 DBMET01883 0.298 0.019 DBMET01884 | ||
| 0.587 | 0.005 | 0.73 | Peroxidase inhibitor | 0.73 0.003 DBMET01883 | DBMET01883 | |
| 0.55 | 0.012 | 0.635 | Antiamyloidogenic | 0.635 0.006 DBMET01883 0.443 0.022 DBMET01884 | DBMET01883 | |
| 0.535 | 0.01 | 0.569 | Superoxide dismutase inhibitor | 0.569 0.008 DBMET01883 | DBMET01883 | |
| 0.542 | 0.03 | 0.552 | Antibacterial | 0.535 0.032 DBMET01883 0.552 0.028 DBMET01884 | DBMET01884 | |
| 0.476 | 0.003 | 0.476 | Farnesoid X receptor antagonist | 0.355 0.004 DBMET01883 0.45 0.003 DBMET01884 | ||
| 0.472 | 0.003 | 0.588 | Carbamoyl phosphate synthetase inhibitor | 0.588 0.001 DBMET01883 0.056 0.047 DBMET01884 | DBMET01883 | |
| 0.475 | 0.015 | 0.475 | DNA synthesis inhibitor | 0.442 0.018 DBMET01883 0.351 0.03 DBMET01884 | ||
| 0.469 | 0.012 | 0.469 | Anticoagulant | 0.427 0.014 DBMET01883 0.184 0.06 DBMET01884 | ||
| 0.456 | 0.002 | 0.456 | Creatine kinase inhibitor | 0.225 0.007 DBMET01883 | ||
| 0.458 | 0.007 | 0.459 | Thrombolytic | 0.459 0.007 DBMET01883 0.21 0.047 DBMET01884 | DBMET01883 | |
| 0.435 | 0.005 | 0.472 | Cell wall synthesis inhibitor | 0.472 0.004 DBMET01883 0.116 0.105 DBMET01884 | DBMET01883 | |
| 0.449 | 0.019 | 0.496 | DNA damaging | 0.457 0.018 DBMET01883 0.496 0.014 DBMET01884 | DBMET01884 | |
| 0.457 | 0.035 | 0.653 | Immunostimulant | 0.653 0.011 DBMET01883 0.544 0.023 DBMET01884 | DBMET01883 | |
| 0.409 | 0.007 | 0.602 | Alkylator | 0.602 0.004 DBMET01883 0.482 0.005 DBMET01884 | DBMET01883 | |
| 0.432 | 0.03 | 0.432 | Antioxidant | 0.347 0.047 DBMET01883 0.325 0.053 DBMET01884 | ||
| 0.392 | 0.005 | 0.595 | Expectorant | 0.595 0.003 DBMET01883 0.367 0.005 DBMET01884 | DBMET01883 | |
| 0.387 | 0.003 | 0.569 | Mucolytic | 0.569 0.002 DBMET01883 0.317 0.004 DBMET01884 | DBMET01883 | |
| 0.388 | 0.005 | 0.388 | GABA C receptor agonist | 0.179 0.025 DBMET01883 | ||
| 0.389 | 0.009 | 0.389 | NOS3 expression enhancer | 0.154 0.068 DBMET01883 0.229 0.031 DBMET01884 | ||
| 0.39 | 0.01 | 0.39 | Bone formation stimulant | 0.273 0.021 DBMET01883 0.163 0.05 DBMET01884 | ||
| 0.382 | 0.004 | 0.463 | Inducible nitric-oxide synthase inhibitor | 0.463 0.003 DBMET01883 0.088 0.05 DBMET01884 | DBMET01883 | |
| 0.367 | 0.002 | 0.367 | Glycine receptor agonist | 0.231 0.003 DBMET01883 0.171 0.005 DBMET01884 | ||
| 0.365 | 0.007 | 0.365 | Protein-tyrosine phosphatase 1B inhibitor | 0.272 0.013 DBMET01883 0.216 0.025 DBMET01884 | ||
| 0.35 | 0.002 | 0.35 | Kinesin-like protein 1 inhibitor | |||
| 0.35 | 0.002 | 0.35 | Kinesin antagonist | |||
| 0.356 | 0.011 | 0.4 | Hemostatic | 0.4 0.008 DBMET01883 0.188 0.038 DBMET01884 | DBMET01883 | |
| 0.345 | 0.004 | 0.345 | Porphobilinogen synthase inhibitor | 0.097 0.037 DBMET01883 | ||
| 0.342 | 0.004 | 0.342 | Phenylalanine 4-hydroxylase inhibitor | 0.281 0.004 DBMET01883 | ||
| 0.331 | 0.004 | 0.403 | Nitric-oxide synthase inhibitor | 0.403 0.003 DBMET01883 | DBMET01883 | |
| 0.326 | 0.005 | 0.415 | Adenylate kinase inhibitor | 0.415 0.003 DBMET01883 | DBMET01883 | |
| 0.313 | 0.004 | 0.313 | Photosensitizer | 0.312 0.004 DBMET01883 0.155 0.028 DBMET01884 | ||
| 0.354 | 0.047 | 0.354 | Calcium channel activator | |||
| 0.309 | 0.004 | 0.309 | CDC25A inhibitor | 0.175 0.009 DBMET01883 0.208 0.006 DBMET01884 | ||
| 0.302 | 0.004 | 0.587 | Ornithine carbamoyltransferase inhibitor | 0.587 0.002 DBMET01883 | DBMET01883 | |
| 0.304 | 0.01 | 0.304 | Succinate dehydrogenase inhibitor | 0.235 0.028 DBMET01883 | ||
| 0.31 | 0.021 | 0.496 | Diuretic | 0.496 0.008 DBMET01883 0.486 0.008 DBMET01884 | DBMET01883 | |
| 0.305 | 0.018 | 0.488 | Phospholipase C inhibitor | 0.488 0.006 DBMET01883 0.485 0.006 DBMET01884 | DBMET01883 | |
| 0.291 | 0.003 | 0.547 | NMDA receptor agonist | 0.547 0.002 DBMET01883 | DBMET01883 | |
| 0.287 | 0.004 | 0.619 | Glutamate decarboxylase inhibitor | 0.619 0.002 DBMET01883 | DBMET01883 | |
| 0.309 | 0.027 | 0.359 | Gastrin inhibitor | 0.359 0.009 DBMET01883 0.306 0.029 DBMET01884 | DBMET01883 | |
| 0.346 | 0.066 | 0.62 | Antithrombotic | 0.554 0.022 DBMET01883 0.62 0.014 DBMET01884 | DBMET01884 | |
| 0.295 | 0.029 | 0.316 | Non-steroidal antiinflammatory agent | 0.316 0.025 DBMET01883 | DBMET01883 | |
| 0.28 | 0.017 | 0.441 | Phospholipase A2 inhibitor | 0.441 0.004 DBMET01883 0.223 0.032 DBMET01884 | DBMET01883 | |
| 0.286 | 0.032 | 0.511 | DNA methylase inhibitor | 0.511 0.005 DBMET01883 | DBMET01883 | |
| 0.297 | 0.049 | 0.297 | Vasodilator | 0.273 0.058 DBMET01883 0.233 0.08 DBMET01884 | ||
| 0.256 | 0.012 | 0.48 | Aminopeptidase B inhibitor | 0.48 0.003 DBMET01883 | DBMET01883 | |
| 0.299 | 0.059 | 0.368 | Insulysin inhibitor | 0.368 0.029 DBMET01883 | DBMET01883 | |
| 0.243 | 0.007 | 0.368 | Hematopoietic | 0.368 0.004 DBMET01883 0.09 0.049 DBMET01884 | DBMET01883 | |
| 0.332 | 0.097 | 0.63 | Antiobesity | 0.248 0.158 DBMET01883 0.63 0.017 DBMET01884 | DBMET01884 | |
| 0.267 | 0.04 | 0.481 | DNA methyltransferase I inhibitor | 0.481 0.005 DBMET01883 | DBMET01883 | |
| 0.283 | 0.059 | 0.324 | Hypoglycemic | 0.324 0.045 DBMET01883 0.223 0.094 DBMET01884 | DBMET01883 | |
| 0.227 | 0.005 | 0.246 | Interferon agonist | 0.246 0.004 DBMET01883 0.101 0.028 DBMET01884 | DBMET01883 | |
| 0.332 | 0.11 | 0.332 | 15-Lipoxygenase inhibitor | |||
| 0.278 | 0.057 | 0.278 | 5 Hydroxytryptamine uptake stimulant | 0.199 0.153 DBMET01883 | ||
| 0.23 | 0.012 | 0.232 | Arachidonic acid antagonist | 0.19 0.043 DBMET01883 0.232 0.011 DBMET01884 | DBMET01884 | |
| 0.212 | 0.003 | 0.212 | Neutral endopeptidase inhibitor | 0.177 0.004 DBMET01883 0.022 0.014 DBMET01884 | ||
| 0.233 | 0.025 | 0.233 | 5 Hydroxytryptamine 3E antagonist | |||
| 0.219 | 0.012 | 0.219 | Beta amyloid protein antagonist | 0.17 0.028 DBMET01883 | ||
| 0.253 | 0.049 | 0.269 | Peptidyltransferase inhibitor | 0.269 0.038 DBMET01883 0.231 0.066 DBMET01884 | DBMET01883 | |
| 0.312 | 0.108 | 0.312 | GABA C receptor rho-3 antagonist | |||
| 0.208 | 0.006 | 0.208 | Sphingosine 1-phosphate receptor 2 antagonist | 0.183 0.013 DBMET01883 | ||
| 0.26 | 0.059 | 0.318 | Tyrosine 3 hydroxylase inhibitor | 0.318 0.025 DBMET01883 | DBMET01883 | |
| 0.201 | 0.01 | 0.201 | TRPA1 agonist | 0.133 0.045 DBMET01883 | ||
| 0.201 | 0.011 | 0.201 | Triose-phosphate isomerase inhibitor | 0.11 0.039 DBMET01883 | ||
| 0.264 | 0.077 | 0.264 | Aldehyde oxidase inhibitor | |||
| 0.195 | 0.011 | 0.195 | NADH dehydrogenase inhibitor | 0.097 0.047 DBMET01883 | ||
| 0.193 | 0.014 | 0.193 | Interleukin 8 antagonist | 0.149 0.034 DBMET01883 | ||
| 0.214 | 0.037 | 0.214 | Acetylcholine M1 receptor antagonist | 0.159 0.066 DBMET01883 0.17 0.058 DBMET01884 | ||
| 0.189 | 0.014 | 0.189 | Alcohol dehydrogenase inhibitor | 0.153 0.02 DBMET01883 | ||
| 0.177 | 0.004 | 0.177 | GABA B receptor antagonist | 0.042 0.031 DBMET01883 | ||
| 0.19 | 0.019 | 0.19 | Adenylate cyclase stimulant | 0.174 0.032 DBMET01883 0.156 0.054 DBMET01884 | ||
| 0.256 | 0.086 | 0.256 | 5 Hydroxytryptamine release stimulant | |||
| 0.231 | 0.063 | 0.231 | RNA-directed DNA polymerase inhibitor | |||
| 0.179 | 0.013 | 0.275 | Phosphofructokinase-1 inhibitor | 0.275 0.006 DBMET01883 | DBMET01883 | |
| 0.186 | 0.021 | 0.186 | GABA receptor agonist | |||
| 0.169 | 0.005 | 0.2 | Cholecystokinin B agonist | 0.2 0.004 DBMET01883 0.043 0.021 DBMET01884 | DBMET01883 | |
| 0.194 | 0.03 | 0.222 | DNA polymerase I inhibitor | 0.171 0.039 DBMET01883 0.222 0.022 DBMET01884 | DBMET01884 | |
| 0.165 | 0.003 | 0.165 | Squalene synthetase inhibitor | 0.103 0.006 DBMET01883 0.085 0.008 DBMET01884 | ||
| 0.175 | 0.014 | 0.175 | Aminoacyl-tRNA synthetase inhibitor | 0.156 0.018 DBMET01883 | ||
| 0.251 | 0.091 | 0.251 | Spasmolytic | 0.218 0.107 DBMET01883 0.163 0.152 DBMET01884 | ||
| 0.164 | 0.004 | 0.166 | Interferon inducer | 0.166 0.004 DBMET01883 0.09 0.017 DBMET01884 | DBMET01883 | |
| 0.189 | 0.041 | 0.289 | Neurotensin receptor agonist | 0.289 0.015 DBMET01883 | DBMET01883 | |
| 0.151 | 0.004 | 0.151 | GABA B receptor agonist | 0.093 0.022 DBMET01883 | ||
| 0.185 | 0.039 | 0.185 | Alpha-N-acetylglucosaminidase inhibitor | 0.168 0.046 DBMET01883 | ||
| 0.169 | 0.025 | 0.169 | Carbonic anhydrase XV inhibitor | |||
| 0.165 | 0.023 | 0.165 | Carbonic anhydrase III inhibitor | 0.094 0.069 DBMET01883 | ||
| 0.273 | 0.132 | 0.456 | Immunosuppressant | 0.361 0.081 DBMET01883 0.456 0.045 DBMET01884 | DBMET01884 | |
| 0.151 | 0.014 | 0.151 | Carbonic anhydrase V inhibitor | 0.08 0.035 DBMET01883 | ||
| 0.14 | 0.004 | 0.146 | Phospholipase D inhibitor | 0.146 0.004 DBMET01883 0.144 0.004 DBMET01884 | DBMET01883 | |
| 0.148 | 0.015 | 0.148 | Histamine N-methyltransferase inhibitor | 0.093 0.053 DBMET01883 | ||
| 0.216 | 0.084 | 0.645 | Hypolipemic | 0.28 0.056 DBMET01883 0.645 0.005 DBMET01884 | DBMET01884 | |
| 0.135 | 0.005 | 0.216 | Glutamate (mGluR group III) agonist | 0.216 0.004 DBMET01883 | DBMET01883 | |
| 0.129 | 0.005 | 0.242 | Leukotriene A4 hydrolase inhibitor | 0.242 0.004 DBMET01883 | DBMET01883 | |
| 0.135 | 0.011 | 0.416 | Bile acid receptor antagonist | 0.131 0.013 DBMET01883 0.416 0.002 DBMET01884 | DBMET01884 | |
| 0.218 | 0.097 | 0.313 | Calpain inhibitor | 0.313 0.025 DBMET01883 | DBMET01883 | |
| 0.126 | 0.005 | 0.563 | Kainate receptor antagonist | 0.563 0.002 DBMET01883 0.037 0.032 DBMET01884 | DBMET01883 | |
| 0.138 | 0.021 | 0.138 | Thioredoxin inhibitor | 0.12 0.03 DBMET01883 | ||
| 0.124 | 0.012 | 0.136 | Aminopeptidase microsomal inhibitor | 0.136 0.01 DBMET01883 | DBMET01883 | |
| 0.138 | 0.028 | 0.138 | Uric acid excretion stimulant | |||
| 0.195 | 0.086 | 0.195 | Anticonvulsant | |||
| 0.191 | 0.083 | 0.297 | Insulin sensitizer | 0.297 0.016 DBMET01883 | DBMET01883 | |
| 0.135 | 0.029 | 0.135 | GABA C receptor rho-1 antagonist | |||
| 0.151 | 0.045 | 0.177 | Cathepsin H inhibitor | 0.177 0.03 DBMET01883 | DBMET01883 | |
| 0.143 | 0.037 | 0.143 | Nav1.4 sodium channel blocker | 0.139 0.039 DBMET01883 | ||
| 0.122 | 0.017 | 0.122 | Carbonic anhydrase VA inhibitor | 0.076 0.04 DBMET01883 | ||
| 0.118 | 0.013 | 0.125 | Acyl-CoA dehydrogenase inhibitor | 0.125 0.012 DBMET01883 | DBMET01883 | |
| 0.144 | 0.04 | 0.144 | Ferrochelatase inhibitor | |||
| 0.108 | 0.009 | 0.108 | S-adenosyl-L-methionine decarboxylase inhibitor | |||
| 0.102 | 0.005 | 0.102 | Mannosidase inhibitor | 0.064 0.014 DBMET01883 | ||
| 0.1 | 0.004 | 0.1 | Purinergic P2Y2 antagonist | 0.043 0.014 DBMET01883 | ||
| 0.098 | 0.004 | 0.098 | Cholecystokinin agonist | 0.085 0.005 DBMET01883 | ||
| 0.107 | 0.014 | 0.107 | Trypsin inhibitor | 0.087 0.023 DBMET01883 | ||
| 0.127 | 0.036 | 0.127 | HIV-1 integrase (Overall Integration) inhibitor | |||
| 0.121 | 0.033 | 0.298 | Catalase inhibitor | 0.298 0.006 DBMET01883 | DBMET01883 | |
| 0.118 | 0.03 | 0.118 | Carbonic anhydrase VI inhibitor | |||
| 0.209 | 0.121 | 0.209 | 5 Hydroxytryptamine 1E antagonist | |||
| 0.11 | 0.023 | 0.194 | Aminopeptidase I inhibitor | 0.194 0.007 DBMET01883 | DBMET01883 | |
| 0.093 | 0.007 | 0.093 | Alpha-mannosidase inhibitor | 0.075 0.014 DBMET01883 | ||
| 0.152 | 0.067 | 0.206 | Lipid peroxidase inhibitor | 0.206 0.039 DBMET01883 0.128 0.086 DBMET01884 | DBMET01883 | |
| 0.088 | 0.004 | 0.16 | Membrane dipeptidase inhibitor | 0.16 0.002 DBMET01883 0.063 0.009 DBMET01884 | DBMET01883 | |
| 0.091 | 0.008 | 0.101 | Lipocortins synthesis agonist | 0.072 0.02 DBMET01883 0.101 0.005 DBMET01884 | DBMET01884 | |
| 0.085 | 0.004 | 0.402 | Calcium-sensing receptor agonist | 0.402 0.002 DBMET01883 | DBMET01883 | |
| 0.098 | 0.019 | 0.098 | Alcohol oxidase inhibitor | |||
| 0.084 | 0.005 | 0.126 | Glucagon receptor antagonist | 0.126 0.004 DBMET01883 | DBMET01883 | |
| 0.093 | 0.015 | 0.253 | Toll-Like receptor 2 agonist | 0.253 0.004 DBMET01883 | DBMET01883 | |
| 0.104 | 0.028 | 0.104 | Purinergic P2X2 antagonist | |||
| 0.079 | 0.004 | 0.079 | Cholecystokinin A agonist | 0.066 0.004 DBMET01883 | ||
| 0.09 | 0.015 | 0.173 | Bombesin 2 receptor antagonist | 0.173 0.008 DBMET01883 | DBMET01883 | |
| 0.091 | 0.018 | 0.091 | Carbonic anhydrase VB inhibitor | |||
| 0.083 | 0.011 | 0.225 | CD45 antagonist | 0.225 0.004 DBMET01883 | DBMET01883 | |
| 0.141 | 0.07 | 0.229 | Histone deacetylase SIRT1 inhibitor | 0.229 0.022 DBMET01883 | DBMET01883 | |
| 0.09 | 0.02 | 0.09 | Purinergic P2X1 antagonist | |||
| 0.107 | 0.037 | 0.121 | Ornithine decarboxylase inhibitor | 0.121 0.025 DBMET01883 | DBMET01883 | |
| 0.099 | 0.032 | 0.336 | Histidine decarboxylase inhibitor | 0.336 0.005 DBMET01883 | DBMET01883 | |
| 0.088 | 0.022 | 0.088 | Beta adrenoreceptor antagonist | 0.077 0.03 DBMET01883 | ||
| 0.184 | 0.119 | 0.184 | Nitric-oxide synthase stimulant | |||
| 0.073 | 0.009 | 0.073 | Histamine H2 receptor agonist | 0.054 0.018 DBMET01883 | ||
| 0.092 | 0.03 | 0.092 | Carbonic anhydrase inhibitor | 0.058 0.047 DBMET01883 | ||
| 0.097 | 0.035 | 0.126 | Na+ K+ transporting ATPase inhibitor | 0.126 0.013 DBMET01884 | DBMET01884 | |
| 0.062 | 0.003 | 0.175 | Ileal bile acid transport inhibitor | 0.13 0.001 DBMET01883 0.175 0.001 DBMET01884 | DBMET01884 | |
| 0.124 | 0.067 | 0.124 | Aldehyde dehydrogenase inhibitor | |||
| 0.065 | 0.009 | 0.065 | Trypsin I inhibitor | 0.047 0.013 DBMET01883 | ||
| 0.069 | 0.013 | 0.069 | Glucose-6-phosphate isomerase inhibitor | |||
| 0.067 | 0.014 | 0.075 | Heparanase inhibitor | 0.075 0.009 DBMET01883 0.067 0.014 DBMET01884 | DBMET01883 | |
| 0.066 | 0.013 | 0.066 | Oxytocin agonist | 0.065 0.013 DBMET01883 | ||
| 0.06 | 0.007 | 0.06 | 3-Hydroxyanthranilate 3,4-dioxygenase inhibitor | |||
| 0.069 | 0.017 | 0.069 | Beta 2 adrenoreceptor antagonist | 0.068 0.018 DBMET01883 | ||
| 0.093 | 0.041 | 0.093 | Carbonic anhydrase XIII inhibitor | |||
| 0.101 | 0.049 | 0.115 | ABCA1 expression enhancer | 0.092 0.061 DBMET01883 0.115 0.034 DBMET01884 | DBMET01884 | |
| 0.07 | 0.02 | 0.103 | Aminopeptidase N inhibitor | 0.103 0.013 DBMET01883 | DBMET01883 | |
| 0.073 | 0.023 | 0.073 | Sphingosine 1-phosphate receptor 3 antagonist | 0.068 0.028 DBMET01883 | ||
| 0.069 | 0.02 | 0.069 | Histamine agonist | |||
| 0.142 | 0.094 | 0.359 | Growth hormone agonist | 0.359 0.022 DBMET01883 0.247 0.044 DBMET01884 | DBMET01883 | |
| 0.055 | 0.009 | 0.085 | Glutamate (mGluR4) agonist | 0.085 0.005 DBMET01883 | DBMET01883 | |
| 0.063 | 0.018 | 0.063 | Purinergic P2Y antagonist | |||
| 0.059 | 0.016 | 0.059 | Dopamine beta hydroxylase inhibitor | |||
| 0.047 | 0.004 | 0.253 | Aminopeptidase A inhibitor | 0.253 0.001 DBMET01883 | DBMET01883 | |
| 0.072 | 0.028 | 0.072 | Carbonic anhydrase XII inhibitor | |||
| 0.12 | 0.077 | 0.168 | Cyclooxygenase 3 inhibitor | 0.168 0.035 DBMET01883 | DBMET01883 | |
| 0.102 | 0.059 | 0.166 | Anabolic | 0.093 0.073 DBMET01883 0.166 0.011 DBMET01884 | DBMET01884 | |
| 0.045 | 0.002 | 0.134 | Glutamate (mGluR6) agonist | 0.134 0.001 DBMET01883 | DBMET01883 | |
| 0.135 | 0.096 | 0.135 | Ca2+-transporting ATPase inhibitor | |||
| 0.103 | 0.064 | 0.103 | Urease inhibitor | 0.094 0.074 DBMET01883 | ||
| 0.072 | 0.034 | 0.077 | NMDA receptor glycine site agonist | 0.077 0.031 DBMET01883 | DBMET01883 | |
| 0.083 | 0.048 | 0.083 | Somatostatin 1 agonist | 0.074 0.058 DBMET01883 | ||
| 0.064 | 0.028 | 0.064 | Ryanodine receptor antagonist | |||
| 0.051 | 0.016 | 0.051 | Dihydropteroate synthase inhibitor | |||
| 0.039 | 0.006 | 0.122 | Glutamate (mGluR1a) agonist | 0.122 0.003 DBMET01883 | DBMET01883 | |
| 0.069 | 0.035 | 0.069 | Beta 3 adrenoreceptor antagonist | |||
| 0.163 | 0.13 | 0.259 | Free radical scavenger | 0.259 0.065 DBMET01883 0.17 0.124 DBMET01884 | DBMET01883 | |
| 0.065 | 0.032 | 0.065 | Beta 2 adrenoreceptor agonist | 0.059 0.056 DBMET01883 | ||
| 0.096 | 0.064 | 0.096 | Sphingomyelinase inhibitor | |||
| 0.086 | 0.054 | 0.086 | GABA A receptor agonist | |||
| 0.066 | 0.034 | 0.066 | Carbonic anhydrase IX inhibitor | |||
| 0.096 | 0.066 | 0.096 | UDP-glucose 4-epimerase inhibitor | |||
| 0.048 | 0.019 | 0.048 | Dopamine D5 agonist | |||
| 0.206 | 0.178 | 0.361 | Interleukin 2 agonist | 0.361 0.041 DBMET01883 0.287 0.083 DBMET01884 | DBMET01883 | |
| 0.04 | 0.012 | 0.052 | Carboxypeptidase B inhibitor | 0.052 0.006 DBMET01883 | DBMET01883 | |
| 0.044 | 0.016 | 0.044 | Phosphoglycerate kinase inhibitor | |||
| 0.094 | 0.067 | 0.094 | Electrolyte absorption antagonist | |||
| 0.058 | 0.031 | 0.058 | Epithelial sodium channel blocker | |||
| 0.275 | 0.248 | 0.275 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | |||
| 0.117 | 0.09 | 0.117 | Alkaline phosphatase inhibitor | |||
| 0.041 | 0.015 | 0.041 | 1-Alkyl-2-acetylglycerophosphocholine esterase inhibitor | 0.031 0.029 DBMET01883 | ||
| 0.029 | 0.005 | 0.029 | Follicle-stimulating hormone antagonist | 0.019 0.015 DBMET01883 | ||
| 0.048 | 0.024 | 0.104 | AICAR transformylase inhibitor | 0.104 0.005 DBMET01883 | DBMET01883 | |
| 0.09 | 0.066 | 0.205 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.205 0.015 DBMET01883 | DBMET01883 | |
| 0.061 | 0.039 | 0.061 | Biliverdin reductase inhibitor | |||
| 0.033 | 0.012 | 0.033 | Purinergic P2T antagonist | |||
| 0.026 | 0.005 | 0.026 | Carbonic anhydrase X inhibitor | 0.015 0.014 DBMET01883 | ||
| 0.026 | 0.005 | 0.026 | Carbonic anhydrase VIII inhibitor | 0.015 0.014 DBMET01883 | ||
| 0.102 | 0.082 | 0.102 | Adenylate cyclase inhibitor | |||
| 0.056 | 0.036 | 0.057 | Sphingosine 1-phosphate receptor 1 antagonist | 0.057 0.036 DBMET01883 | DBMET01883 | |
| 0.033 | 0.013 | 0.033 | 5 Hydroxytryptamine 6 agonist | |||
| 0.035 | 0.015 | 0.035 | Purinergic P2X agonist | |||
| 0.046 | 0.026 | 0.046 | Dihydrofolate reductase inhibitor | |||
| 0.033 | 0.014 | 0.086 | Lysine carboxypeptidase inhibitor | 0.086 0.004 DBMET01883 | DBMET01883 | |
| 0.04 | 0.022 | 0.059 | Glutamate (mGluR8) agonist | 0.059 0.007 DBMET01883 | DBMET01883 | |
| 0.055 | 0.039 | 0.055 | Carbonic anhydrase II inhibitor | |||
| 0.056 | 0.04 | 0.056 | Beta 1 adrenoreceptor antagonist | |||
| 0.08 | 0.064 | 0.08 | Dual specificity tyrosine-phosphorylation regulated kinase 2 inhibitor | |||
| 0.048 | 0.032 | 0.056 | Bombesin antagonist | 0.056 0.022 DBMET01883 | DBMET01883 | |
| 0.05 | 0.035 | 0.078 | Lysophosphatidic acid 3 receptor antagonist | 0.078 0.01 DBMET01883 | DBMET01883 | |
| 0.019 | 0.004 | 0.019 | Carbonic anhydrase XI inhibitor | |||
| 0.065 | 0.051 | 0.083 | Glutamate (mGluR6) antagonist | 0.083 0.021 DBMET01883 | DBMET01883 | |
| 0.038 | 0.024 | 0.075 | Arginase inhibitor | 0.075 0.007 DBMET01883 | DBMET01883 | |
| 0.043 | 0.028 | 0.043 | Sphingosine 1-phosphate receptor 1 agonist | 0.038 0.037 DBMET01883 | ||
| 0.051 | 0.037 | 0.051 | Aconitate hydratase inhibitor | |||
| 0.047 | 0.034 | 0.047 | Glutamate (mGluR group I) agonist | |||
| 0.03 | 0.017 | 0.03 | Purinergic P2Y15 antagonist | |||
| 0.056 | 0.043 | 0.056 | Adenosine A1 receptor antagonist | |||
| 0.055 | 0.042 | 0.132 | Argininosuccinate synthase inhibitor | 0.132 0.014 DBMET01883 | DBMET01883 | |
| 0.043 | 0.03 | 0.043 | Carbonic anhydrase IV inhibitor | 0.042 0.031 DBMET01883 | ||
| 0.036 | 0.024 | 0.039 | Tryptophan 5 hydroxylase inhibitor | 0.039 0.018 DBMET01883 | DBMET01883 | |
| 0.051 | 0.04 | 0.051 | Dipeptidyl peptidase inhibitor | |||
| 0.019 | 0.009 | 0.019 | Sodium/hydrogen exchanger inhibitor | |||
| 0.018 | 0.008 | 0.018 | Purinergic P2Y1 agonist | |||
| 0.028 | 0.019 | 0.028 | Uridine phosphorylase inhibitor | |||
| 0.07 | 0.062 | 0.071 | GABA aminotransferase inhibitor | 0.071 0.06 DBMET01883 | DBMET01883 | |
| 0.098 | 0.09 | 0.296 | Cholesterol synthesis inhibitor | 0.296 0.012 DBMET01884 | DBMET01884 | |
| 0.024 | 0.017 | 0.024 | 5 Hydroxytryptamine 4 agonist | |||
| 0.043 | 0.036 | 0.043 | Glutamate (mGluR5) agonist | |||
| 0.024 | 0.017 | 0.074 | Glutamate (mGluR1) agonist | 0.074 0.004 DBMET01883 | DBMET01883 | |
| 0.034 | 0.027 | 0.046 | Renin inhibitor | 0.046 0.02 DBMET01883 | DBMET01883 | |
| 0.019 | 0.012 | 0.02 | Methylmalonyl-CoA mutase inhibitor | 0.02 0.009 DBMET01883 | DBMET01883 | |
| 0.074 | 0.067 | 0.074 | MAP kinase kinase 7 inhibitor | |||
| 0.031 | 0.025 | 0.032 | Dipeptidyl peptidase II inhibitor | 0.032 0.024 DBMET01883 | DBMET01883 | |
| 0.051 | 0.046 | 0.051 | Mannitol-1-phosphate 5-dehydrogenase inhibitor | |||
| 0.012 | 0.008 | 0.012 | Purine nucleoside phosphorylase inhibitor | |||
| 0.025 | 0.022 | 0.025 | Hypoxanthine phosphoribosyltransferase inhibitor | |||
| 0.068 | 0.065 | 0.068 | Glutamate receptor agonist | |||
| 0.044 | 0.042 | 0.094 | Thromboxane A2 antagonist | 0.064 0.025 DBMET01883 0.094 0.009 DBMET01884 | DBMET01884 | |
| 0.072 | 0.069 | 0.072 | Adrenaline agonist | |||
| 0.018 | 0.016 | 0.018 | Antibiotic Anthracycline-like | |||
| 0.04 | 0.039 | 0.04 | Histamine H1 receptor agonist | |||
| 0.134 | 0.133 | 0.134 | Anesthetic general | |||
| 0.048 | 0.047 | 0.048 | 3(or 17)beta-hydroxysteroid dehydrogenase inhibitor | |||
| 0.041 | 0.04 | 0.041 | Dipeptidyl peptidase IV inhibitor | |||
| 0.049 | 0.05 | 0.078 | Angiotensin-converting enzyme inhibitor | 0.078 0.014 DBMET01883 | DBMET01883 | |
| 0.073 | 0.074 | 0.099 | NMDA receptor antagonist | 0.099 0.048 DBMET01883 | DBMET01883 | |
| 0.086 | 0.087 | 0.106 | Monophenol monooxygenase inhibitor | 0.106 0.071 DBMET01883 | DBMET01883 | |
| 0.032 | 0.034 | 0.104 | Farnesoid X receptor agonist | 0.104 0.004 DBMET01884 | DBMET01884 | |
| 0.2 | 0.202 | 0.309 | Histamine release inhibitor | 0.309 0.119 DBMET01883 | DBMET01883 | |
| 0.029 | 0.031 | 0.03 | Fumarate hydratase inhibitor | 0.03 0.029 DBMET01883 | DBMET01883 | |
| 0.037 | 0.041 | 0.051 | Kainate receptor agonist | 0.051 0.013 DBMET01883 | DBMET01883 | |
| 0.01 | 0.015 | 0.043 | N-Acetylated alpha-linked acidic dipeptidase inhibitor | 0.043 0.004 DBMET01883 | DBMET01883 | |
| 0.043 | 0.05 | 0.098 | Thromboxane antagonist | 0.058 0.033 DBMET01883 0.098 0.012 DBMET01884 | DBMET01884 | |
| 0.005 | 0.013 | 0.009 | Phosphoribosylglycinamide formyltransferase inhibitor | 0.009 0.004 DBMET01883 | DBMET01883 | |
| 0.069 | 0.078 | 0.082 | Glycine receptor antagonist | 0.082 0.054 DBMET01884 | DBMET01884 | |
| 0.063 | 0.073 | 0.1 | Metalloproteinase-9 inhibitor | 0.1 0.032 DBMET01883 | DBMET01883 | |
| 0.06 | 0.07 | 0.072 | Thrombin inhibitor | 0.072 0.053 DBMET01883 | DBMET01883 | |
| 0.048 | 0.059 | 0.116 | Carbonic anhydrase stimulant | 0.116 0.015 DBMET01883 | DBMET01883 | |
| 0.01 | 0.022 | 0.032 | Prostacyclin agonist | 0.032 0.005 DBMET01884 | DBMET01884 | |
| 0.09 | 0.103 | 0.115 | Acetylcholine muscarinic antagonist | 0.115 0.072 DBMET01884 | DBMET01884 | |
| 0.029 | 0.042 | 0.034 | Ceramide glucosyltransferase inhibitor | 0.034 0.027 DBMET01884 | DBMET01884 | |
| 0.019 | 0.033 | 0.028 | Lysophosphatidic acid receptor 1 agonist | 0.028 0.013 DBMET01883 | DBMET01883 | |
| 0.02 | 0.034 | 0.065 | Cholecystokinin B antagonist | 0.065 0.008 DBMET01883 | DBMET01883 | |
| 0.096 | 0.112 | 0.218 | Toll-Like receptor 2 antagonist | 0.218 0.017 DBMET01883 | DBMET01883 | |
| 0.026 | 0.049 | 0.034 | Glutamate (mGluR3) agonist | 0.034 0.017 DBMET01883 | DBMET01883 | |
| 0.043 | 0.066 | 0.056 | Vanilloid 2 antagonist | 0.056 0.028 DBMET01883 | DBMET01883 | |
| 0.051 | 0.076 | 0.066 | Protease 3C (Human rhinovirus) inhibitor | 0.066 0.041 DBMET01883 | DBMET01883 | |
| 0.099 | 0.124 | 0.108 | Antibacterial (Helicobacter pylori) | 0.108 0.103 DBMET01883 | DBMET01883 | |
| 0.03 | 0.056 | 0.044 | Neurokinin 2 agonist | 0.044 0.025 DBMET01883 | DBMET01883 | |
| 0.086 | 0.113 | 0.154 | Factor V inhibitor | 0.154 0.017 DBMET01883 | DBMET01883 | |
| 0.057 | 0.092 | 0.126 | Metalloproteinase-2 inhibitor | 0.126 0.027 DBMET01883 | DBMET01883 | |
| 0.019 | 0.055 | 0.039 | Calcitonin receptor agonist | 0.039 0.021 DBMET01883 | DBMET01883 | |
| 0.017 | 0.054 | 0.092 | Cholecystokinin A antagonist | 0.092 0.01 DBMET01883 | DBMET01883 | |
| 0.009 | 0.047 | 0.026 | Integrin beta3 antagonist | 0.026 0.01 DBMET01883 | DBMET01883 | |
| 0.038 | 0.077 | 0.065 | Matrix metalloproteinase (membrane-type) inhibitor | 0.065 0.028 DBMET01883 | DBMET01883 | |
| 0.017 | 0.057 | 0.085 | Cholecystokinin antagonist | 0.085 0.01 DBMET01883 | DBMET01883 | |
| 0.05 | 0.091 | 0.092 | Cathepsin G inhibitor | 0.092 0.037 DBMET01883 | DBMET01883 | |
| 0.038 | 0.085 | 0.079 | Autotaxin inhibitor | 0.079 0.019 DBMET01884 | DBMET01884 | |
| 0.046 | 0.098 | 0.059 | Neuraminidase (influenza) inhibitor | 0.059 0.057 DBMET01883 | DBMET01883 | |
| 0.025 | 0.078 | 0.096 | Antimetabolite | 0.096 0.017 DBMET01883 | DBMET01883 | |
| 0.041 | 0.094 | 0.053 | DNA helicase inhibitor | 0.053 0.041 DBMET01883 | DBMET01883 | |
| 0.005 | 0.059 | 0.038 | Kainate receptor 1 antagonist | 0.038 0.008 DBMET01883 | DBMET01883 | |
| 0.022 | 0.084 | 0.091 | Ribonucleotide reductase inhibitor | 0.091 0.023 DBMET01883 | DBMET01883 | |
| 0.033 | 0.095 | 0.113 | Selectin antagonist | 0.113 0.024 DBMET01883 0.057 0.052 DBMET01884 | DBMET01883 | |
| 0.022 | 0.087 | 0.091 | Ribonucleoside-diphosphate reductase inhibitor | 0.091 0.021 DBMET01883 | DBMET01883 | |
| 0.014 | 0.08 | 0.11 | GP IIb/IIIa receptor antagonist | 0.11 0.016 DBMET01883 | DBMET01883 | |
| 0.011 | 0.078 | 0.021 | Tryptophan hydroxylase 1 inhibitor | 0.021 0.005 DBMET01883 | DBMET01883 | |
| 0.026 | 0.095 | 0.042 | Neuraminidase (Influenza A) inhibitor | 0.042 0.037 DBMET01883 | DBMET01883 | |
| 0.044 | 0.116 | 0.083 | Analgesic, opioid | 0.083 0.044 DBMET01883 | DBMET01883 | |
| 0.023 | 0.097 | 0.06 | AMPA 4 receptor antagonist | 0.06 0.01 DBMET01883 | DBMET01883 | |
| 0.022 | 0.098 | 0.076 | Thymidylate synthase inhibitor | 0.076 0.009 DBMET01883 | DBMET01883 | |
| 0.007 | 0.083 | 0.035 | Vitronectin receptor antagonist | 0.035 0.009 DBMET01883 | DBMET01883 | |
| 0.033 | 0.113 | 0.076 | Matrix metalloproteinase inhibitor | 0.076 0.04 DBMET01883 | DBMET01883 | |
| 0.092 | 0.179 | 0.137 | Vanilloid 1 agonist | 0.137 0.055 DBMET01883 | DBMET01883 | |
| 0.055 | 0.142 | 0.198 | Glutathione S-transferase inhibitor | 0.198 0.005 DBMET01883 | DBMET01883 | |
| 0.028 | 0.118 | 0.094 | Glucagon-like peptide 1 agonist | 0.094 0.026 DBMET01883 | DBMET01883 | |
| 0.027 | 0.118 | 0.045 | Glutamate (mGluR4) antagonist | 0.045 0.028 DBMET01883 | DBMET01883 | |
| 0.039 | 0.134 | 0.071 | Adenine nucleotide translocase inhibitor | 0.071 0.014 DBMET01883 | DBMET01883 | |
| 0.017 | 0.115 | 0.037 | Hedgehog signaling activator | 0.037 0.005 DBMET01884 | DBMET01884 | |
| 0.029 | 0.128 | 0.069 | Androgen agonist | 0.069 0.031 DBMET01884 | DBMET01884 | |
| 0.022 | 0.126 | 0.073 | Neutrophil collagenase inhibitor | 0.073 0.037 DBMET01883 | DBMET01883 | |
| 0.066 | 0.178 | 0.089 | Glutamate (mGluR7) agonist | 0.089 0.085 DBMET01883 | DBMET01883 | |
| 0.05 | 0.166 | 0.075 | Estrogen receptor alpha antagonist | 0.075 0.058 DBMET01884 | DBMET01884 | |
| 0.022 | 0.147 | 0.044 | Neurotensin receptor antagonist | 0.044 0.032 DBMET01883 | DBMET01883 | |
| 0.014 | 0.139 | 0.059 | Carbonic anhydrase I stimulant | 0.059 0.012 DBMET01883 | DBMET01883 | |
| 0.094 | 0.222 | 0.287 | Interleukin agonist | 0.287 0.054 DBMET01883 | DBMET01883 | |
| 0.136 | 0.264 | 0.44 | Immunomodulator | 0.44 0.034 DBMET01883 0.189 0.177 DBMET01884 | DBMET01883 | |
| 0.029 | 0.157 | 0.065 | Carbonic anhydrase II stimulant | 0.065 0.018 DBMET01883 | DBMET01883 | |
| 0.008 | 0.16 | 0.064 | Kainate receptor 2 antagonist | 0.064 0.01 DBMET01883 | DBMET01883 | |
| 0.013 | 0.182 | 0.057 | Macrophage elastase inhibitor | 0.057 0.02 DBMET01883 | DBMET01883 | |
| 0.123 | 0.293 | 0.181 | Neuropeptide Y2 antagonist | 0.181 0.158 DBMET01883 | DBMET01883 | |
| 0.008 | 0.189 | 0.028 | Bradykinin B2 receptor agonist | 0.028 0.02 DBMET01883 | DBMET01883 | |
| 0.015 | 0.2 | 0.025 | Toll-Like receptor 4 agonist | 0.025 0.024 DBMET01884 | DBMET01884 | |
| 0.007 | 0.193 | 0.075 | Complement C3a chemotactic receptor antagonist | 0.075 0.016 DBMET01883 | DBMET01883 | |
| 0.012 | 0.206 | 0.073 | Glycine transporter 2 inhibitor | 0.073 0.019 DBMET01883 | DBMET01883 | |
| 0.174 | 0.373 | 0.472 | Antiinflammatory | 0.472 0.1 DBMET01884 | DBMET01884 | |
| 0.077 | 0.277 | 0.35 | Platelet antagonist | 0.35 0.038 DBMET01883 0.29 0.056 DBMET01884 | DBMET01883 | |
| 0.043 | 0.251 | 0.165 | Histone deacetylase class III inhibitor | 0.165 0.034 DBMET01883 | DBMET01883 | |
| 0.044 | 0.265 | 0.106 | Caspase 3 inhibitor | 0.106 0.082 DBMET01883 | DBMET01883 | |
| 0.017 | 0.253 | 0.057 | Glutamate (mGluR8) antagonist | 0.057 0.006 DBMET01883 | DBMET01883 | |
| 0.003 | 0.241 | 0.014 | Carbonic anhydrase IV stimulant | 0.014 0.012 DBMET01883 | DBMET01883 | |
| 0.023 | 0.264 | 0.091 | Sirtuin 1 inhibitor | 0.091 0.028 DBMET01883 | DBMET01883 | |
| 0.058 | 0.315 | 0.143 | Thiol protease inhibitor | 0.143 0.076 DBMET01883 | DBMET01883 | |
| 0.018 | 0.29 | 0.128 | Androgen antagonist | 0.128 0.029 DBMET01884 | DBMET01884 | |
| 0.08 | 0.354 | 0.234 | Transcription factor NF kappa B inhibitor | 0.234 0.139 DBMET01884 | DBMET01884 | |
| 0.006 | 0.295 | 0.077 | Estrogen agonist | 0.077 0.024 DBMET01884 | DBMET01884 | |
| 0.056 | 0.35 | 0.183 | Platelet adhesion inhibitor | 0.18 0.082 DBMET01883 0.183 0.08 DBMET01884 | DBMET01884 | |
| 0.031 | 0.344 | 0.087 | Factor XII inhibitor | 0.087 0.053 DBMET01883 | DBMET01883 | |
| 0.046 | 0.363 | 0.221 | Interleukin antagonist | 0.221 0.074 DBMET01883 | DBMET01883 | |
| 0.008 | 0.326 | 0.073 | Antineoplastic antibiotic | 0.073 0.062 DBMET01884 | DBMET01884 | |
| 0.004 | 0.326 | 0.027 | Kainate receptor 5 antagonist | 0.027 0.011 DBMET01883 | DBMET01883 | |
| 0.028 | 0.363 | 0.068 | Caspase 9 inhibitor | 0.068 0.034 DBMET01883 | DBMET01883 | |
| 0.005 | 0.344 | 0.051 | Glucocorticoid antagonist | 0.051 0.015 DBMET01884 | DBMET01884 | |
| 0.018 | 0.383 | 0.063 | Bombesin 1 receptor agonist | 0.063 0.038 DBMET01883 | DBMET01883 | |
| 0.005 | 0.385 | 0.089 | Integrin antagonist | 0.089 0.018 DBMET01883 | DBMET01883 | |
| 0.021 | 0.455 | 0.109 | Estrogen receptor beta antagonist | 0.109 0.048 DBMET01884 | DBMET01884 | |
| 0.034 | 0.514 | 0.21 | Nitric oxide antagonist | 0.21 0.064 DBMET01884 | DBMET01884 | |
| 0.004 | 0.534 | 0.033 | AMPA receptor agonist | 0.033 0.028 DBMET01883 | DBMET01883 | |
| 0.003 | 0.548 | 0.071 | HMG CoA reductase inhibitor | 0.071 0.004 DBMET01884 | DBMET01884 | |
| 0.018 | 0.573 | 0.072 | Chymotrypsin inhibitor | 0.072 0.068 DBMET01883 | DBMET01883 | |
| 0.011 | 0.595 | 0.121 | Cell adhesion molecule inhibitor | 0.121 0.024 DBMET01883 | DBMET01883 | |
| 0.037 | 0.622 | 0.166 | Folate antagonist | 0.166 0.017 DBMET01883 | DBMET01883 | |
| 0.012 | 0.62 | 0.097 | Protease inhibitor | 0.097 0.068 DBMET01883 | DBMET01883 | |
| 0.015 | 0.641 | 0.136 | Estrogen antagonist | 0.136 0.031 DBMET01884 | DBMET01884 | |
| 0.027 | 0.671 | 0.086 | Transcription factor NF kappa B stimulant | 0.086 0.057 DBMET01883 | DBMET01883 | |
| 0.005 | 0.652 | 0.036 | Integrin alpha5beta1 antagonist | 0.036 0.035 DBMET01883 | DBMET01883 | |
| 0.002 | 0.734 | 0.02 | Corticosteroid-like | 0.02 0.016 DBMET01884 | DBMET01884 | |
| 0.003 | 0.818 | 0.03 | AMPA 2 receptor antagonist | 0.03 0.02 DBMET01883 | DBMET01883 | |
| 0.008 | 0.828 | 0.155 | Cell adhesion inhibitor | 0.155 0.044 DBMET01883 | DBMET01883 | |
| 0.002 | 0.825 | 0.017 | Kainate receptor 3 antagonist | 0.017 0.012 DBMET01883 | DBMET01883 | |
| 0.015 | 0.84 | 0.309 | Apoptosis agonist | 0.309 0.166 DBMET01884 | DBMET01884 | |
| 0.01 | 0.857 | 0.048 | Glucose-6-phosphate dehydrogenase inhibitor | 0.048 0.013 DBMET01884 | DBMET01884 | |
| 0.005 | 0.893 | 0.021 | Vitamin D receptor antagonist | 0.021 0.018 DBMET01884 | DBMET01884 | |
| 0.002 | 0.932 | 0.033 | Prostaglandin D2 agonist | 0.033 0.019 DBMET01884 | DBMET01884 | |
| 0.008 | 0.941 | 0.038 | Integrin alpha1beta1 antagonist | 0.038 0.027 DBMET01883 | DBMET01883 | |
| 0 | 0.934 | 0.055 | RNA-directed RNA polymerase stimulant | 0.055 0.012 DBMET01884 | DBMET01884 | |
| 0.02 | 0.968 | 0.383 | Lipocortins synthesis antagonist | 0.383 0.01 DBMET01884 | DBMET01884 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |